These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23814487)

  • 1. Loss of Sh3gl2/endophilin A1 is a common event in urothelial carcinoma that promotes malignant behavior.
    Majumdar S; Gong EM; Di Vizio D; Dreyfuss J; Degraff DJ; Hager MH; Park PJ; Bellmunt J; Matusik RJ; Rosenberg JE; Adam RM
    Neoplasia; 2013 Jul; 15(7):749-60. PubMed ID: 23814487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SH3GL2 is frequently deleted in non-small cell lung cancer and downregulates tumor growth by modulating EGFR signaling.
    Dasgupta S; Jang JS; Shao C; Mukhopadhyay ND; Sokhi UK; Das SK; Brait M; Talbot C; Yung RC; Begum S; Westra WH; Hoque MO; Yang P; Yi JE; Lam S; Gazdar AF; Fisher PB; Jen J; Sidransky D
    J Mol Med (Berl); 2013 Mar; 91(3):381-93. PubMed ID: 22968441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-330-mediated regulation of SH3GL2 expression enhances malignant behaviors of glioblastoma stem cells by activating ERK and PI3K/AKT signaling pathways.
    Yao Y; Xue Y; Ma J; Shang C; Wang P; Liu L; Liu W; Li Z; Qu S; Li Z; Liu Y
    PLoS One; 2014; 9(4):e95060. PubMed ID: 24736727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of SH3GL2 promotes the migration and invasion behaviours of glioblastoma cells through activating the STAT3/MMP2 signalling.
    Zhu Y; Zhang X; Wang L; Ji Z; Xie M; Zhou X; Liu Z; Shi H; Yu R
    J Cell Mol Med; 2017 Nov; 21(11):2685-2694. PubMed ID: 28470949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SH3GL2 gene participates in MEK-ERK signal pathway partly by regulating EGFR in the laryngeal carcinoma cell line Hep2.
    Shang C; Guo Y; Fu S; Fu W; Sun K
    Med Sci Monit; 2010 Jun; 16(6):BR168-73. PubMed ID: 20512084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of EGFR in head and neck squamous cell carcinoma is associated with inactivation of SH3GL2 and CDC25A genes.
    Maiti GP; Mondal P; Mukherjee N; Ghosh A; Ghosh S; Dey S; Chakrabarty J; Roy A; Biswas J; Roychoudhury S; Panda CK
    PLoS One; 2013; 8(5):e63440. PubMed ID: 23675485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of Wnt5a expression with histopathological grade/stage in urothelial carcinoma of the bladder.
    Malgor R; Crouser S; Greco D; Brockett C; Coschigano K; Nakazawa M; Jenkinson S
    Diagn Pathol; 2013 Aug; 8():139. PubMed ID: 23947922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
    Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.
    Hsieh HY; Jou YC; Tung CL; Tsai YS; Wang YH; Chi CL; Lin RI; Hung SK; Chuang YM; Wu SF; Li C; Shen CH; Chan MWY; Hsu CD
    Oncogene; 2018 Feb; 37(5):673-686. PubMed ID: 29035390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis.
    Liu H; Bi J; Dong W; Yang M; Shi J; Jiang N; Lin T; Huang J
    Mol Cancer; 2018 Nov; 17(1):161. PubMed ID: 30458784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SH3BGRL3 Protein as a Potential Prognostic Biomarker for Urothelial Carcinoma: A Novel Binding Partner of Epidermal Growth Factor Receptor.
    Chiang CY; Pan CC; Chang HY; Lai MD; Tzai TS; Tsai YS; Ling P; Liu HS; Lee BF; Cheng HL; Ho CL; Chen SH; Chow NH
    Clin Cancer Res; 2015 Dec; 21(24):5601-11. PubMed ID: 26286913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Interleukin-1-Receptor-Antagonist in Bladder Cancer Cell Migration and Invasion.
    Schneider L; Liu J; Zhang C; Azoitei A; Meessen S; Zheng X; Cremer C; Gorzelanny C; Kempe-Gonzales S; Brunner C; Wezel F; Bolenz C; Gunes C; John A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.
    DeGraff DJ; Clark PE; Cates JM; Yamashita H; Robinson VL; Yu X; Smolkin ME; Chang SS; Cookson MS; Herrick MK; Shariat SF; Steinberg GD; Frierson HF; Wu XR; Theodorescu D; Matusik RJ
    PLoS One; 2012; 7(5):e36669. PubMed ID: 22590586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Nie L; Gui Y; Cai Z
    Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression and DNA methylation regulation of arsenic in mouse bladder tissues and in human urothelial cells.
    Jou YC; Wang SC; Dai YC; Chen SY; Shen CH; Lee YR; Chen LC; Liu YW
    Oncol Rep; 2019 Sep; 42(3):1005-1016. PubMed ID: 31322264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
    Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
    Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in T24 cells.
    Xu ST; Ding X; Ni QF; Jin SJ
    Int J Clin Exp Pathol; 2015; 8(7):7937-44. PubMed ID: 26339359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High NF-κB and STAT3 activity in human urothelial carcinoma: a pilot study.
    Degoricija M; Situm M; Korać J; Miljković A; Matić K; Paradžik M; Marinović Terzić I; Jerončić A; Tomić S; Terzić J
    World J Urol; 2014 Dec; 32(6):1469-75. PubMed ID: 24448750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grainyhead-Like 3 Influences Migration and Invasion of Urothelial Carcinoma Cells.
    Wezel F; Lustig J; Azoitei A; Liu J; Meessen S; Najjar G; Zehe V; Faustmann P; Zengerling F; John A; Martini T; Bolenz C; Günes C
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma.
    Chan TC; Wu WJ; Li WM; Shiao MS; Shiue YL; Li CF
    Theranostics; 2020; 10(25):11775-11793. PubMed ID: 33052246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.